세계의 유전체학용 실험실 자동화 시장 보고서(2025년)
Lab Automation In Genomics Global Market Report 2025
상품코드 : 1825433
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

유전체학용 실험실 자동화 시장 규모는 향후 수년간 급성장이 전망됩니다. 2029년에는 CAGR 14.3%로 45억 6,000만 달러로 성장합니다. 예측 기간의 성장은 POC(Point-Of-Care) 검사의 확대, 클라우드 기반 솔루션으로의 전환, 실시간 및 지속적인 모니터링에 대한 집중, 정밀농업의 확대, 멀티오믹스 통합의 부상 등에 기인합니다. 예측 기간의 주요 동향으로는 자동화 장비 채택, 실험실 자동화 시스템 채택, 자동화 기술, 클라우드 기반 플랫폼 등이 있습니다.

향후 5년간 14.3%의 성장률 전망은 지난번 예측보다 0.4% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 인상은 독일과 싱가포르에서 공급되는 고처리량 로봇 분주 시스템 및 PCR 자동화 모듈의 비용을 높이고, 운영 지연을 악화시키며, 게놈 검사의 확장성을 제한함으로써 미국 연구기관에 부담을 줄 가능성이 높습니다. 또한 상호 관세와 무역 긴장과 제한 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

정밀의료의 채택이 증가함에 따라 예측 가능한 미래에 유전체학 시장에서 실험실 자동화가 확대될 것으로 보입니다. 헬스케어에 대한 개인 맞춤형 접근을 특징으로 하는 정밀의료는 유전자, 환경, 라이프스타일의 개인차를 고려하여 맞춤형 의료 요법을 제공합니다. 정밀의료에 대한 수요 증가는 유전체학의 발전, 표적치료, 환자 중심 의료, 의약품 개발 등 다양한 요인에 기인합니다. 정밀의료는 질병 관련 유전자를 확인하기 위한 유전자 검사에 크게 의존하므로 검사실은 대량의 샘플을 신속하고 정확하게 처리해야 하는 과제에 직면해 있으며, 자동화 시스템 도입이 과제입니다. 예를 들어 미국 비영리단체인 맞춤형 의료연합(Personalized Medicine Coalition)이 제공한 2024년 2월 데이터에 따르면 FDA는 2022년 6건이었던 희귀질환에 대한 신규 개인맞춤형 치료제를 2023년 16건 승인한 것으로 나타났습니다. 이는 정밀의료의 채택이 크게 증가하고 있음을 의미하며, 이는 유전체학 시장에서 실험실 자동화에 대한 수요를 촉진하고 있습니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세 및 Covid와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 대기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 합병과 인수

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSA
영문 목차

영문목차

Lab automation in genomics refers to the utilization of advanced technologies and systems to streamline and automate diverse laboratory processes integral to genomic research and analysis. By leveraging lab automation, the objective is to enhance the efficiency, accuracy, and reproducibility of genomic studies while minimizing manual errors, increasing throughput, and expediting data analysis.

The primary types of lab automation in genomics encompass automated liquid handlers, automated plate handlers, robotic arms, and automated storage and retrieval systems, among others. Automated liquid handlers are specialized laboratory instruments engineered to accurately dispense precise volumes of liquids automatically, thereby optimizing processes such as sample preparation and assay setup. These devices significantly enhance efficiency and accuracy across various genomic workflows. Lab automation in genomics operates through a variety of processes, including continuous automation systems and modular automation systems. These automation solutions find application across diverse sectors, including hospitals and private labs, biotech and pharmaceutical companies, academic and research institutes, and other relevant industries.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The lab automation in genomics market research report is one of a series of new reports from The Business Research Company that provides lab automation in genomics market statistics, including the lab automation in genomics industry global market size, regional shares, competitors with a lab automation in genomics market share, detailed lab automation in genomics market segments, market trends and opportunities, and any further data you may need to thrive in the lab automation in genomics industry. This lab automation in genomics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab automation in genomics market size has grown rapidly in recent years. It will grow from $2.33 billion in 2024 to $2.68 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to the increased demand for precision medicine, rise in the complexity of genomic data, increased focus on genomic research, increased adoption in clinical diagnostics, demand for scalability and flexibility.

The lab automation in genomics market size is expected to see rapid growth in the next few years. It will grow to $4.56 billion in 2029 at a compound annual growth rate (CAGR) of 14.3%. The growth in the forecast period can be attributed to the expansion of point-of-care testing, shift towards cloud-based solutions, focus on real-time and continuous monitoring, expansion of precision agriculture, rise of multi-omics integration. Major trends in the forecast period include the adoption of automated instruments, adoption of lab automation systems, automated technologies, cloud-based platforms.

The forecast of 14.3% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. research institutions by driving up the cost of high-throughput robotic pipetting systems and PCR automation modules sourced from Germany and Singapore, exacerbating operational delays and limiting genomic testing scalability. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing adoption of precision medicine is poised to drive the expansion of lab automation within the genomics market in the foreseeable future. Precision medicine, characterized by its personalized approach to healthcare, takes into account individual variations in genes, environment, and lifestyle to deliver tailored medical therapies. The growing demand for precision medicine is attributed to various factors, including advancements in genomics, targeted therapies, patient-centric care, and drug development. As precision medicine relies heavily on genetic testing to identify disease-related genes, laboratories are faced with the challenge of processing a large number of samples quickly and accurately, prompting the adoption of automated systems. For instance, data from February 2024, provided by the Personalized Medicine Coalition, a US-based non-profit organization, revealed that the FDA approved 16 novel personalized therapies for rare diseases in 2023, compared to six in 2022. This indicates a significant uptick in the adoption of precision medicine, thereby driving the demand for lab automation in the genomics market.

Leading companies in lab automation within the genomics market are focusing on developing advanced solutions such as automated whole genome sequencing (WGS) to advance genomics research, clinical diagnostics, and personalized medicine significantly. Automated whole genome sequencing involves sequencing an individual's genome using high-throughput, automated sequencing technologies. For example, in May 2023, Clear Labs, Inc., a US-based genomics testing company, introduced Clear Dx, a new solution offering fully automated sample processing. Clear Dx ensures precise and consistent library preparation and management for genomics applications. The automation provided by Clear Dx reduces human variability, ensures consistency throughout sequencing, and streamlines genome sequencing processes. It reduces hands-on time to just 30 minutes with a single touchpoint, making whole genome sequencing accessible even without specialized training.

In October 2022, Ginkgo Bioworks, a US-based biotechnology company, completed the acquisition of Zymergen for an undisclosed sum. This strategic acquisition is geared towards accelerating the development of Ginkgo's horizontal synthetic biology platform by integrating critical automation and software technologies, including machine learning and data science tools. These technologies enhance exploration in both known and unexplored genetic design areas. Zymergen, a US-based biotechnology company specializing in automation technology, brings expertise in improving the efficiency and reliability of lab operations within genomics services.

Major companies operating in the lab automation in genomics market report are Pfizer Inc.; Robert Bosch GmbH; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Novartis International AG; GlaxoSmithKline plc; Danaher Corporation; Becton, Dickinson and Company; Agilent Technologies Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen N.V.; Tecan Group Ltd.; Illumina Inc.; Hamilton Company; Promega Corporation; Oxford Nanopore Technologies Ltd.; Fluidigm Corporation; Gilson Incorporated

North America was the largest region in the lab automation in genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab automation in genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab automation in genomics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lab automation in genomics market consists of revenues earned by entities by providing services such as sample preparation, sequencing library preparation, data analysis, sample tracking and management, quality control, customization, and integration. The market value includes the value of related goods sold by the service provider or included within the service offering. The lab automation in genomics market also includes sales of centrifuges, thermal cyclers, sequencing platforms, PCR automation systems, and robotic workstations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab Automation In Genomics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on lab automation in genomics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for lab automation in genomics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab automation in genomics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Lab Automation In Genomics Market Characteristics

3. Lab Automation In Genomics Market Trends And Strategies

4. Lab Automation In Genomics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lab Automation In Genomics Growth Analysis And Strategic Analysis Framework

6. Lab Automation In Genomics Market Segmentation

7. Lab Automation In Genomics Market Regional And Country Analysis

8. Asia-Pacific Lab Automation In Genomics Market

9. China Lab Automation In Genomics Market

10. India Lab Automation In Genomics Market

11. Japan Lab Automation In Genomics Market

12. Australia Lab Automation In Genomics Market

13. Indonesia Lab Automation In Genomics Market

14. South Korea Lab Automation In Genomics Market

15. Western Europe Lab Automation In Genomics Market

16. UK Lab Automation In Genomics Market

17. Germany Lab Automation In Genomics Market

18. France Lab Automation In Genomics Market

19. Italy Lab Automation In Genomics Market

20. Spain Lab Automation In Genomics Market

21. Eastern Europe Lab Automation In Genomics Market

22. Russia Lab Automation In Genomics Market

23. North America Lab Automation In Genomics Market

24. USA Lab Automation In Genomics Market

25. Canada Lab Automation In Genomics Market

26. South America Lab Automation In Genomics Market

27. Brazil Lab Automation In Genomics Market

28. Middle East Lab Automation In Genomics Market

29. Africa Lab Automation In Genomics Market

30. Lab Automation In Genomics Market Competitive Landscape And Company Profiles

31. Lab Automation In Genomics Market Other Major And Innovative Companies

32. Global Lab Automation In Genomics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lab Automation In Genomics Market

34. Recent Developments In The Lab Automation In Genomics Market

35. Lab Automation In Genomics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기